Matthews PM - Search Results

1

Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease.

Arnold DL, Matthews PM, Francis G, Antel J. Arnold DL, et al. Among authors: matthews pm. Magn Reson Med. 1990 Apr;14(1):154-9. doi: 10.1002/mrm.1910140115. Magn Reson Med. 1990. PMID: 2161982

2

Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis.

Ciccarelli O, Toosy AT, Marsden JF, Wheeler-Kingshott CM, Miller DH, Matthews PM, Thompson AJ. Ciccarelli O, et al. Among authors: matthews pm. J Neurol. 2006 Jul;253(7):882-91. doi: 10.1007/s00415-006-0125-z. Epub 2006 Apr 20. J Neurol. 2006. PMID: 16619123

3

Relating neocortical pathology to disability progression in multiple sclerosis using MRI.

Chen JT, Narayanan S, Collins DL, Smith SM, Matthews PM, Arnold DL. Chen JT, et al. Among authors: matthews pm. Neuroimage. 2004 Nov;23(3):1168-75. doi: 10.1016/j.neuroimage.2004.07.046. Neuroimage. 2004. PMID: 15528116 Clinical Trial.

4

MRI in the diagnosis and management of multiple sclerosis.

Arnold DL, Matthews PM. Arnold DL, et al. Among authors: matthews pm. Neurology. 2002 Apr 23;58(8 Suppl 4):S23-31. doi: 10.1212/wnl.58.8_suppl_4.s23. Neurology. 2002. PMID: 11971123 Review.

5

Proton MR spectroscopy in multiple sclerosis.

Arnold DL, De Stefano N, Narayanan S, Matthews PM. Arnold DL, et al. Among authors: matthews pm. Neuroimaging Clin N Am. 2000 Nov;10(4):789-98 ,ix-x. Neuroimaging Clin N Am. 2000. PMID: 11359725 Review.

6

Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.

De Stefano N, Narayanan S, Matthews PM, Mortilla M, Dotti MT, Federico A, Arnold DL. De Stefano N, et al. Among authors: matthews pm. J Neurovirol. 2000 May;6 Suppl 2:S121-9. J Neurovirol. 2000. PMID: 10871799 Review.

7

Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.

Lee MA, Blamire AM, Pendlebury S, Ho KH, Mills KR, Styles P, Palace J, Matthews PM. Lee MA, et al. Among authors: matthews pm. Arch Neurol. 2000 Jan;57(1):65-70. doi: 10.1001/archneur.57.1.65. Arch Neurol. 2000. PMID: 10634450

8

In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis.

De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP, Arnold DL. De Stefano N, et al. Among authors: matthews pm. Brain. 1999 Oct;122 ( Pt 10):1933-9. doi: 10.1093/brain/122.10.1933. Brain. 1999. PMID: 10506094

9

Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease.

Matthews PM, Ford B, Dandurand RJ, Eidelman DH, O'Connor D, Sherwin A, Karpati G, Andermann F, Arnold DL. Matthews PM, et al. Neurology. 1993 May;43(5):884-90. doi: 10.1212/wnl.43.5.884. Neurology. 1993. PMID: 8492942

10

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, Federico A, Smith SM. De Stefano N, et al. Among authors: matthews pm. Neurology. 2003 Apr 8;60(7):1157-62. doi: 10.1212/01.wnl.0000055926.69643.03. Neurology. 2003. PMID: 12682324 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results